| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,267 |
8,739 |
$292K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,264 |
4,632 |
$278K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
621 |
573 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,514 |
1,412 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,061 |
985 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
269 |
248 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
728 |
662 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
113 |
109 |
$6K |
| 74018 |
|
408 |
362 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
66 |
64 |
$2K |
| 72100 |
|
55 |
53 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
29 |
25 |
$906.32 |
| 80061 |
Lipid panel |
76 |
68 |
$586.07 |
| 99406 |
|
60 |
49 |
$504.23 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,764 |
1,416 |
$311.94 |
| 73560 |
|
15 |
12 |
$264.12 |
| 93000 |
|
27 |
24 |
$257.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
26 |
26 |
$208.74 |
| 82962 |
|
106 |
96 |
$189.06 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
361 |
297 |
$102.12 |
| 36415 |
Collection of venous blood by venipuncture |
423 |
368 |
$92.53 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,035 |
862 |
$81.47 |
| 81003 |
|
136 |
122 |
$56.29 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
457 |
389 |
$45.87 |